Company · CIK 1114448
NOVARTIS AG
| CIK | 1114448 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | V8 |
| Business address | Switzerland |
| Listed | NVS (NYSE), NVSEF (OTC) |
| First annual or quarterly report | 2001-04-11 |
Offerings
0 registrationsNo offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.
Filings
20| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-17 | 424B5Shelf takedown | 333-282133 | 0001104659-26-029551 |
| 2026-03-16 | 424B5Shelf takedown | 333-282133 | 0001104659-26-028048 |
| 2025-11-04 | 424B5Shelf takedown | 333-282133 | 0001104659-25-106338 |
| 2025-11-03 | 424B5Shelf takedown | 333-282133 | 0001104659-25-105278 |
| 2024-09-17 | 424B5Shelf takedown | 333-282133 | 0001104659-24-100712 |
| 2024-09-16 | 424B5Shelf takedown | 333-282133 | 0001104659-24-100040 |
| 2020-02-12 | 424B5Shelf takedown | 333-236162 | 0001047469-20-000837 |
| 2020-02-11 | 424B5Shelf takedown | 333-236162 | 0001047469-20-000795 |
| 2017-02-15 | 424B5Shelf takedown | 333-207004 | 0001047469-17-000686 |
| 2017-02-14 | 424B5Shelf takedown | 333-207004 | 0001047469-17-000659 |
| 2015-11-18 | 424B5Shelf takedown | 333-207004 | 0001047469-15-008772 |
| 2015-11-17 | 424B5Shelf takedown | 333-207004 | 0001047469-15-008723 |
| 2014-02-19 | 424B5Shelf takedown | 333-183955 | 0001047469-14-001027 |
| 2014-02-18 | 424B5Shelf takedown | 333-183955 | 0001047469-14-000961 |
| 2012-09-19 | 424B5Shelf takedown | 333-183955 | 0001047469-12-008953 |
| 2012-09-18 | 424B5Shelf takedown | 333-183955 | 0001047469-12-008899 |
| 2011-02-25 | EFFECTDeclared effective | 333-171381 | 9999999995-11-000545 |
| 2010-03-10 | 424B5Shelf takedown | 333-153696 | 0001047469-10-001989 |
| 2010-03-09 | 424B5Shelf takedown | 333-153696 | 0001047469-10-001907 |
| 2009-02-03 | 424B5Shelf takedown | 333-153696 | 0001047469-09-000541 |